Last paragraph of the Musick profile on Neuromics CEO Pete Shuster's blog......
In our interview, Jim gave blinding glimpses of the future especially with regard to new products to extend Vitro Biopharma's offering of clinical tools to fully explore the ever-expanding therapeutic applications of MSCs. I am excited about the potential. I will keep you posted as new products are commercialized.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.